SCHEMBL21652987

SCHEMBL21652987

CCn1cc(NC(=O)c2ccc3c(c2)OCO3)ccc1=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 11/20 0.64
▸ NPC1 O15118 10/20 0.64
▸ SMN1; SMN2 Q16637 8/20 0.64
▸ MAPT P10636 5/20 0.64
▸ NFKB1 P19838 2/20 0.64
▸ NFKB2 Q00653 2/20 0.64
▸ RELA Q04206 2/20 0.64
▸ PKM P14618 2/20 0.64
▸ ALDH1A1 P00352 1/20 0.64
▸ KMT2A Q03164 4/20 0.62
▸ TSHR P16473 2/20 0.61
▸ L3MBTL1 Q9Y468 1/20 0.61
▸ CYP1A2 P05177 1/20 0.60
▸ CYP3A4 P08684 1/20 0.60
▸ CASP3 P42574 4/20 0.59
▸ SENP7 Q9BQF6 4/20 0.59
▸ MEN1 O00255 3/20 0.59
▸ TP53 P04637 2/20 0.58
▸ HTT P42858 1/20 0.58
▸ NR0B1 P51843 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21653176 0.79 MEN1 (0.58) RAB9ANPC1SMN1; SMN2MAPTPKM
SCHEMBL108116 0.79 NPC1 (1.00) RAB9ANPC1SMN1; SMN2MAPTNFKB1
SCHEMBL21652915 0.77 CREBBP (0.55) RAB9ANPC1MAPTALDH1A1KMT2A
SCHEMBL21653182 0.77 KMT2A (0.52) RAB9ANPC1SMN1; SMN2MAPTKMT2A
SCHEMBL6848423 0.77 RAB9A (0.84) RAB9ANPC1SMN1; SMN2MAPTNFKB1
SCHEMBL21652920 0.77 MAPT (0.42) RAB9ANPC1MAPTKMT2ACYP1A2
SCHEMBL8768779 0.76 RAB9A (0.82) RAB9ANPC1SMN1; SMN2MAPTNFKB1
SCHEMBL21653184 0.76 KCNQ3 (0.53) RAB9ANPC1SMN1; SMN2MAPTPKM
SCHEMBL21653193 0.76 KCNQ3 (0.53) RAB9ANPC1MAPTPKMKMT2A
SCHEMBL21653177 0.76 MAPT (0.46) RAB9ANPC1SMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020023657-A1 PYRIDIN-2-ONE COMPOUNDS USEFUL AS SMARCA2 ANTAGONISTS Epizyme, Inc. (US) 2020-01-30 — — WO disclosed
Send feedback